Literature DB >> 21782475

Intraoperative neurophysiological responses in epileptic patients submitted to hippocampal and thalamic deep brain stimulation.

Arthur Cukiert1, Cristine Mella Cukiert, Meire Argentoni-Baldochi, Carla Baise, Cássio Roberto Forster, Valeria Antakli Mello, José Augusto Burattini, Alessandra Moura Lima.   

Abstract

PURPOSE: Deep brain stimulation (DBS) has been used in an increasing frequency for treatment of refractory epilepsy. Acute deep brain macrostimulation intraoperative findings were sparsely published in the literature. We report on our intraoperative macrostimulation findings during thalamic and hippocampal DBS implantation.
METHODS: Eighteen patients were studied. All patients underwent routine pre-operative evaluation that included clinical history, neurological examination, interictal and ictal EEG, high resolution 1.5T MRI and neuropsychological testing. Six patients with temporal lobe epilepsy were submitted to hippocampal DBS (Hip-DBS); 6 patients with focal epilepsy were submitted to anterior thalamic nucleus DBS (AN-DBS) and 6 patients with generalized epilepsy were submitted to centro-median thalamic nucleus DBS (CM-DBS). Age ranged from 9 to 40 years (11 males). All patients were submitted to bilateral quadripolar DBS electrode implantation in a single procedure, under general anesthesia, and intraoperative scalp EEG monitoring. Final electrode's position was checked postoperatively using volumetric CT scanning. Bipolar stimulation using the more proximal and distal electrodes was performed. Final standard stimulation parameters were 6Hz, 4V, 300μs (low frequency range: LF) or 130Hz, 4V, 300μs (high frequency range: HF). KEY
FINDINGS: Bilateral recruiting response (RR) was obtained after unilateral stimulation in all patients submitted to AN and CM-DBS using LF stimulation. RR was widespread but prevailed over the fronto-temporal region bilaterally, and over the stimulated hemisphere. HF stimulation led to background slowing and a DC shift. The mean voltage for the appearance of RR was 4V (CM) and 3V (AN). CM and AN-DBS did not alter inter-ictal spiking frequency or morphology. RR obtained after LF Hip-DBS was restricted to the stimulated temporal lobe and no contralateral activation was noted. HF stimulation yielded no visually recognizable EEG modification. Mean intensity for initial appearance of RR was 3V. In 5 of the 6 patients submitted to Hip-DBS, an increase in inter-ictal spiking was noted unilaterally immediately after electrode insertion. Intraoperative LF stimulation did not modify temporal lobe spiking; on the other hand, HF was effective in abolishing inter-ictal spiking in 4 of the 6 patients studied. There was no immediate morbidity or mortality in this series. SIGNIFICANCE: Macrostimulation might be used to confirm that the hardware was working properly. There was no typical RR derived from each studied thalamic nuclei after LF stimulation. On the other hand, absence of such RRs was highly suggestive of hardware malfunction or inadequate targeting. Thalamic-DBS (Th-DBS) RR was always bilateral after unilateral stimulation, although they somehow prevailed over the stimulated hemisphere. Contrary to Th-DBS, Hip-DBS gave rise to localized RR over the ipsolateral temporal neocortex, and absence of this response might very likely be related to inadequate targeting or hardware failure. Increased spiking was seen over temporal neocortex during hippocampal electrode insertion; this might point to the more epileptogenic hippocampal region in each individual patient. We did not notice any intraoperative response difference among patients with temporal lobe epilepsy with or without MTS. The relationship between these intraoperative findings and seizure outcome is not yet clear and should be further evaluated. 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21782475     DOI: 10.1016/j.seizure.2011.07.003

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  9 in total

Review 1.  Deep brain stimulation for the treatment of epilepsy: circuits, targets, and trials.

Authors:  Nealen G Laxpati; Willard S Kasoff; Robert E Gross
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

2.  Deep brain stimulation for refractory temporal lobe epilepsy: a systematic review and meta-analysis with an emphasis on alleviation of seizure frequency outcome.

Authors:  Bowen Chang; Jiwen Xu
Journal:  Childs Nerv Syst       Date:  2017-09-18       Impact factor: 1.475

Review 3.  UltraHigh Field MR Imaging in Epilepsy.

Authors:  Gaurav Verma; Bradley N Delman; Priti Balchandani
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-02       Impact factor: 2.266

4.  Cerebrospinal Fluid Egress from the Quadripolar Deep Brain Stimulation Electrode for Anterior Nucleus of the Thalamus for Refractory Epilepsy.

Authors:  Byung-Chul Son; Jin-Gyu Choi; Sang-Woo Ha
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

5.  Epilepsy and Neuromodulation-Randomized Controlled Trials.

Authors:  Churl-Su Kwon; Valeria Ripa; Omar Al-Awar; Fedor Panov; Saadi Ghatan; Nathalie Jetté
Journal:  Brain Sci       Date:  2018-04-18

6.  The Appearance Order of Varying Intervals Introduces Extra Modulation Effects on Neuronal Firing Through Non-linear Dynamics of Sodium Channels During High-Frequency Stimulations.

Authors:  Lvpiao Zheng; Zhouyan Feng; Hanhan Hu; Zhaoxiang Wang; Yue Yuan; Xuefeng Wei
Journal:  Front Neurosci       Date:  2020-05-19       Impact factor: 4.677

7.  Deep brain stimulation for refractory epilepsy.

Authors:  Tomasz Tykocki; Tomasz Mandat; Anna Kornakiewicz; Henryk Koziara; Paweł Nauman
Journal:  Arch Med Sci       Date:  2012-10-08       Impact factor: 3.318

Review 8.  Neurostimulation as a promising epilepsy therapy.

Authors:  Yicong Lin; Yuping Wang
Journal:  Epilepsia Open       Date:  2017-08-23

Review 9.  How technology is driving the landscape of epilepsy surgery.

Authors:  Christian Dorfer; Bertil Rydenhag; Gordon Baltuch; Vivek Buch; Jeffrey Blount; Robert Bollo; Jason Gerrard; Daniel Nilsson; Karl Roessler; James Rutka; Ashwini Sharan; Dennis Spencer; Arthur Cukiert
Journal:  Epilepsia       Date:  2020-03-29       Impact factor: 6.740

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.